Cargando…
Is neuroblastoma screening evaluation needed and feasible?
Despite the five million children who have been screened for neuroblastoma in Japan through detection of catecholamine metabolites, it is still uncertain whether screening for this disease is beneficial. The Japanese study has clearly indicated that screening at 6 months or earlier leads to heavy ov...
Autores principales: | Estève, J., Parker, L., Roy, P., Herrmann, F., Duffy, S., Frappaz, D., Lasset, C., Hill, C., Sancho-Garnier, H., Michaelis, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033839/ https://www.ncbi.nlm.nih.gov/pubmed/7779698 |
Ejemplares similares
-
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression.
por: Combaret, V., et al.
Publicado: (1997) -
Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.
por: Favrot, M. C., et al.
Publicado: (1986) -
The LMCE5 unselected cohort of 25 children consecutively diagnosed with untreated stage 4 neuroblastoma over 1 year at diagnosis
por: Frappaz, D, et al.
Publicado: (2002) -
Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
por: Philip, T., et al.
Publicado: (1993) -
Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial
por: Berthold, Frank, et al.
Publicado: (2021)